Nothing said here yet.
to join the conversation.
| J.H. Whitney Equity Partners VII, LLC | Sell | 2,250,000 | $25.9M | Fri, Aug 21 |
| VIGANO PAUL R | Sell | 2,250,000 | $25.9M | Fri, Aug 21 |
| WILLIAMS ROBERT M JR | Sell | 2,250,000 | $25.9M | Fri, Aug 21 |
| WILLIAMS ROBERT M JR | Sell | 10,112,125 | $116.3M | Thu, Aug 20 |
| VIGANO PAUL R | Sell | 10,112,125 | $116.3M | Thu, Aug 20 |
| J.H. Whitney Equity Partners VII, LLC | Sell | 10,112,125 | $116.3M | Thu, Aug 20 |
| WILLIAMS ROBERT M JR | Sell | 1,813,795 | $20.9M | Thu, Aug 20 |
| VIGANO PAUL R | Sell | 1,813,795 | $20.9M | Thu, Aug 20 |
| WILLIAMS ROBERT M JR | Sell | 1,426,034 | $16.4M | Thu, Aug 20 |
| VIGANO PAUL R | Sell | 1,426,034 | $16.4M | Thu, Aug 20 |
| J.H. Whitney Equity Partners VII, LLC | Sell | 1,426,034 | $16.4M | Thu, Aug 20 |
| VIGANO PAUL R | Sell | 957,918 | $11.0M | Thu, Aug 20 |
Aveanna Healthcare Holdings has delivered a very strong multi year share price run, which puts a sharp spotlight on what investors are currently paying for its earnings.
Aveanna Healthcare Holdings (AVAH) has drawn attention after a Zacks Rank of #2 coincided with a roughly 14.1% uplift in full year earnings estimates over the past 3 months.
Here is how Aveanna Healthcare (AVAH) and Elanco Animal Health Incorporated (ELAN) have performed compared to their sector so far this year.
Investors need to pay close attention to AVAH stock based on the movements in the options market lately.
Aveanna (AVAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here is how Aveanna Healthcare (AVAH) and Charles River Laboratories (CRL) have performed compared to their sector so far this year.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks.
A caller asked for Jim Cramer’s long-term thoughts on Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) during the lightning round of the September 14 episode of Mad Money. He replied: They have a good model.
Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Aveanna (AVAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.